Michael Thomas Byrne

4.0k citations
107 papers · 3.0k · 1 hit paper · h-index 27

Impact in

  • Hematology top 1%
    • Acute Myeloid Leukemia Research
    • Hematopoietic Stem Cell Transplantation
    • Chronic Myeloid Leukemia Treatments
  • Oncology top 5%
    • CAR-T cell therapy research

Papers in

    • Hematopoietic Stem Cell Transplantation 35
    • Acute Myeloid Leukemia Research 32
    • Chronic Myeloid Leukemia Treatments 12
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 9

Michael Thomas Byrne

103 papers receiving 2.9k citations

Michael Thomas Byrne's Hit Papers

Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3 2024 · 117 citations
1170+1Years since publication255075100

Peers

Michael Thomas Byrne
Comparison fields: 5 of 114
  • Hematology 1.3k
  • Oncology 757
  • Genetics 225
  • Cancer Research 296
  • Transplantation 49
Replace Yoshiyuki Kosaka with:
Yoshiyuki Kosaka Japan
Hiroaki Goto Japan
Masahiro Masuya Japan
Michael Keeney Canada
Marie E. Robert United States
Shahram Y. Kordasti United Kingdom
Kai Hübel Germany
Yubin Kang United States
Isao Tawara Japan
Ronan Foley Canada
Michael Thomas Byrne relative to Yoshiyuki Kosaka Japan Yoshiyuki Kosaka's profile →
Citations per field
00.5×2×3.0×
Yoshiyuki Kosaka · 1×
Citations per year

Countries citing papers authored by Michael Thomas Byrne

Since Specialization
Citations

This map shows the geographic impact of Michael Thomas Byrne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Thomas Byrne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Thomas Byrne more than expected).

Fields of papers citing papers by Michael Thomas Byrne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Thomas Byrne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Thomas Byrne. The network helps show where Michael Thomas Byrne may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Thomas Byrne, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Thomas Byrne Line = papers co-authored together Michael Thomas Byrne links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 107 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2013321
2 2020263
3 2016178
4 2019151
5
Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3
Hit paper breakdown →
2024117
6 2022115
7 2012100
8 201999
9 199581
10 201974
11 201974
12 201871
13 202165
14 198862
15 202055
16 202052
17 201848
18 201747
19 201843
20 201042

About Michael Thomas Byrne

Michael Thomas Byrne is a scholar working on Hematology, Genetics, Oncology, Public Health, Environmental and Occupational Health and Immunology, having authored 107 papers that have together received 3.0k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (35 papers), Acute Myeloid Leukemia Research (32 papers), Acute Lymphoblastic Leukemia research (16 papers), Immune Cell Function and Interaction (12 papers), Chronic Myeloid Leukemia Treatments (12 papers), CAR-T cell therapy research (10 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers) and Childhood Cancer Survivors' Quality of Life (6 papers). The work is most often cited by research in Hematology (1.3k citations), Oncology (757 citations), Genetics (225 citations), Cancer Research (296 citations) and Transplantation (49 citations). Michael Thomas Byrne has collaborated with scholars based in United States, Italy and France. Frequent co-authors include Bipin Savani, Richard D. Kim, Bassam N. Estfan, Crystal MacKenzie, Mamoru Yanagimachi, Judy Oestreicher, Ken Aoshima, François P. Bernier, Zoltán Dezső and Pavan Kumar. Their work appears in journals such as Transplantation and Cellular Therapy, Blood, Bone Marrow Transplantation, Blood Advances and British Journal of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact